Trial reportJournal of traditional Chinese medicine = Chung i tsa chih ying wen pan2023
Long-term efficacy of point application therapy on different acupoints and durations in the treatment of asthma: a randomized controlled trial.
Trial report in Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Effect of point application therapy for bronchial asthma: a multicenter randomized controlled trial.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2026Trial
- Acupuncture with different frequencies for tobacco dependence: a randomized controlled trial.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2025Trial
- Acupuncture for Persistent Asthma: Protocol for a Randomized, Sham-Controlled Trial with Neuroimaging.Journal of asthma and allergy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo optimise point application therapy for the treatment of asthma.
methodsA total of 456 patients with asthma were randomly divided into treatment groups 1, 2, and 3, with 152 patients each. The Dazhui (GV14), Feishu (BL13), Xinshu (BL15), Geshu (BL17), Pishu (BL20), Shenshu (BL23), and Guanyuan (CV4) acupoints were selected for treatment groups 1 and 2, with 2 and 4 h of application, respectively. The Feishu (BL13), Xinshu (BL15), and Geshu (BL17) acupoints were selected in group 3, with 2 h of application. All patients underwent application of the "prevention of disease" plaster during the dog days of summer (approximately July and August each year) between 2015 and 2019.
resultsThe analysis showed that the numbers of asthma attacks and total serum immunoglobulin E (IgE) levels of the three groups after treatment were significantly lower than those before treatment. In addition, the reductions in treatment groups 1 and 2 were more significant than those in group 3. The total treatment efficacy rates and post-treatment quality of life scores of the patients in treatment groups 1 and 2 were significantly higher than those in group 3.
conclusionsPoint application therapy can effectively improve the clinical symptoms of patients with asthma, reduce the number of attacks, improve the quality of life, and decrease the total serum IgE level. The choice of acupuncture points, but not the length of the application time, influenced the therapeutic effect of point application therapy in asthma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.